Geneva, May 29 -- International Clinical Trials Registry received information related to the study (ChiCTR2600125220) titled 'Rapid Achievement of Target Tacrolimus Concentrations with Extended-Release Formulation: A Single-Center, Prospective, Open-Label, Randomized Controlled Study' on May 22.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Southern Medical University Southern Hospital
Condition:
Immune rejection after kidney transplantation
Intervention:
Control group:Standard-dose extended-release tacrolimus regimen
Recruitment Status: Recruiting
Phase: 4
Date of First Enrollment: 2025-09-02
Target Sample Size: Control group:59;Loading-dose extended-release tacrolimus group:59;
Countries of Re...